Perspectives of oral cephalosporins in upper respiratory tract infections.
Negri
M C
MC
Department of Microbiology, Ramón y Cajal Hospital, Madrid, Spain.
Morosini
M I
MI
Loza
E
E
Baquero
F
F
D000284:Administration, Oral; D002511:Cephalosporins / Q000008:administration & dosage*; D002648:Child; D006192:Haemophilus Infections / Q000188:drug therapy*; D019741:Haemophilus influenzae type b / Q000187:drug effects; D006801:Humans; D001936:Moraxella catarrhalis / Q000187:drug effects; D016870:Neisseriaceae Infections / Q000188:drug therapy*; D010033:Otitis Media / Q000188:drug therapy; D010406:Penicillins / Q000008:administration & dosage / Q000627:therapeutic use; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D013290:Streptococcal Infections / Q000188:drug therapy*; D013297:Streptococcus pyogenes / Q000187:drug effects
D002511:Cephalosporins; D010406:Penicillins